Similar articles

• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy.

  Horiot JC, Le Fur R, N'Guyen T, Chenal C, Schraub S, Alfonsi S, Gardani G, Van Den Bogaert W, Danczak S, Bolla M, et al. Horiot JC, et al. Radiother Oncol. 1992 Dec;25(4):231-41. doi: 10.1016/0167-8140(92)90242-m. Radiother Oncol. 1992. PMID: 1480768 Clinical Trial.
• [Carcinoma of the oropharynx extended to the base of the tongue: radiosurgical treatment with intraoperative radiotherapy].

  Schmitt T, Prades J, Pinto N, Puel G, Barbet N, Calloc'h F. Schmitt T, et al. Bull Cancer Radiother. 1996;83(2):79-85. Bull Cancer Radiother. 1996. PMID: 8688223 French.
• Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.

  Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG. Mendenhall WM, et al. Laryngoscope. 2010 Nov;120(11):2218-22. doi: 10.1002/lary.21144. Laryngoscope. 2010. PMID: 20938964
• Altered fractionated radiation therapy for head and neck carcinomas--A Massachusetts General Hospital experience.

  Wang CC. Wang CC. Ann Acad Med Singap. 1996 May;25(3):335-40. Ann Acad Med Singap. 1996. PMID: 8876897 Review.
• [ORL brachytherapy. Brachytherapy of squamous cell carcinoma of the oropharynx].

  Hoffstetter S. Hoffstetter S. Bull Cancer Radiother. 1995;82(2):191-8. Bull Cancer Radiother. 1995. PMID: 7546890 Review. French. No abstract available.